Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2003
05/14/2003EP1309693A2 Anti-dual integrin antibodies, compositions, methods and uses
05/14/2003EP1309692A2 Anti-il-12 antibodies, compositions, methods and uses
05/14/2003EP1309691A2 Anti-tnf antibodies, compositions, methods and uses
05/14/2003EP1309690A2 Mfq-111, a novel human gtpase like protein
05/14/2003EP1309689A2 Genes involved in immune related responses observed with asthma
05/14/2003EP1309687A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof
05/14/2003EP1309685A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309682A2 Tetraspan protein and uses thereof
05/14/2003EP1309679A2 Human genes and gene expression products
05/14/2003EP1309675A2 Recombinant proteolytic tryptases, active site mutants thereof, and methods of making same
05/14/2003EP1309627A1 Immunotherapy for chronic myelocytic leukemia
05/14/2003EP1309626A2 Cng2b: a putative human cyclic nucleotide-gated ion channel
05/14/2003EP1309625A2 Therapeutic compounds for ovarian cancer
05/14/2003EP1309620A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
05/14/2003EP1309606A1 T1r taste receptors and genes encoding same
05/14/2003EP1309374A2 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
05/14/2003EP1309348A2 Prophylactic and therapeutic monoclonal antibodies against vaccinia virus antigens
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309346A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
05/14/2003EP1309341A2 Prevention and treatment of alzheimer's disease
05/14/2003EP1267940B1 Compounds for targeting
05/14/2003EP1140987B1 Peptides for inhibiting hpv e6 proteins
05/14/2003EP0991946B1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor
05/14/2003EP0958382B1 Novel method for testing the differentiation status in pancreatic cells of a mammal
05/14/2003EP0799314B1 PROBIN TYROSINE KINASE (PYK2) ITS cDNA CLONING AND ITS USES
05/14/2003EP0753065B1 Antibodies against e-selectin
05/14/2003EP0666919B1 Vaccine containing a thiol protease
05/14/2003EP0656014B1 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
05/14/2003CN1418225A Monoclonal antibodies to the human ldl receptor, their production and use
05/14/2003CN1418222A Novel peptide and screening method by using the same
05/14/2003CN1417232A Production process of extracting antibody immune globulin from hen's egg
05/14/2003CN1417223A CR1 gene related to cell reconstitution, conduction and death
05/13/2003WO2004039826A1 Anti-il-6 antibodies, compositions, methods and uses
05/13/2003WO2002040048A2 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
05/13/2003US6562950 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions
05/13/2003US6562948 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity
05/13/2003US6562946 Human procalcitonin and the preparation and use thereof
05/13/2003US6562801 PpGpp and pppGpp as immunomodulatory agents
05/13/2003US6562799 DNA binding proteins that are modified such that they are stable under non-hypoxic as well as hypoxic conditions
05/13/2003US6562632 Reactive dye for use as diagnostic tool in the analysis of biological systems
05/13/2003US6562622 Continuous in vitro evolution
05/13/2003US6562618 Monoclonal antibody for use in the treatment of connective tissue, cancers, arteriosclerotic, skin and kidney disorders
05/13/2003US6562614 ADP-ribosylation factor-like proteins
05/13/2003US6562599 Single-stranded antibody against hepatitis B virus core protein, gene thereof, and therapeutic agent for hepatitis B containing these
05/13/2003US6562596 Provides purified and isolated polypeptide products having primary structural conformation and biological properties of naturally occurring mammalian tissue inhibitor of metalloproteinase type three
05/13/2003US6562593 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/13/2003US6562591 Cell cycle protein for use in the diagnosis and tratment of cancer and cell proliferative disorders
05/13/2003US6562589 AIB1, a novel steroid receptor co-activator
05/13/2003US6562580 Detection of preferential binding protein; obtain kinase protein, incubate with potential binding protein, monitor activity of kinase, adjustment in activity indicates bound protein
05/13/2003US6562579 Diagnosing autoimmune disease; obtain sample, incubate with antibody, determine the concentration of preferential cytokine protein in sample, comparing to control, adjustment in cytokine concentration indicates autoimmune disease
05/13/2003US6562344 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003US6562342 Preventives/remedies for inflammatory intestinal disease
05/13/2003US6562341 Antibodies specific for native PrPSc
05/13/2003US6562333 Purified mammalian CTLA-8 antigens and related reagents
05/13/2003CA2467719A1 Anti-il-6 antibodies, compositions, methods and uses
05/13/2003CA2428649A1 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis
05/13/2003CA2105998C Human pf4a receptors and their use
05/13/2003CA2105979C Monoclonal antibody against lps core
05/13/2003CA2096933C Compounds and compositions which inhibit bone resorption
05/13/2003CA2086131C Anti-human ige monoclonal antibodies
05/08/2003WO2003038098A2 5t4 ligand
05/08/2003WO2003038097A1 Ubiquitin-specific protease occurring in the brain and dna encoding the same
05/08/2003WO2003038096A1 Receptor for angiogenesis inhibitor and method of screening angiogenesis inhibitor
05/08/2003WO2003038088A1 Molecular diagnosis method for multiple myeloma
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038043A2 Combinations of dr5 antibody and other therapeutic agents
05/08/2003WO2003037934A1 Method for assay of protein kinase a activity using anti-phosphokemptide antibody in diagnosis of cancer
05/08/2003WO2003037921A1 Immunointeractive molecules and uses thereof
05/08/2003WO2003037918A2 Pyranosone dehydratase from phanerochaete chrysosporium
05/08/2003WO2003037913A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003WO2003037911A2 Antibodies for inhibiting blood coagulation and methods of use thereof
05/08/2003WO2003037400A2 Methods and device compositions for the recruitment of cells to blood contacting surfaces in vivo
05/08/2003WO2003037251A2 Hivgp120-induced bob/gpr15 activation
05/08/2003WO2003037247A2 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty
05/08/2003WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy
05/08/2003WO2003037080A1 Nonhuman model animal of systemic lupus erythematosus
05/08/2003WO2003025138A3 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
05/08/2003WO2003023404A8 A method of diagnosis and treatment and agents useful for same
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2002098908A3 Osteoclastogenesis inhibitory factor, sequence coding for it and uses
05/08/2003WO2002090974A3 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
05/08/2003WO2002090524A3 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
05/08/2003WO2002079230A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002050118A3 Single-strand antibody with improved stability
05/08/2003WO2002048335A3 Metal resistant plants and use for phytoremediation
05/08/2003WO2002046222A3 Compositions and methods for diagnosing alzheimer's disease
05/08/2003WO2002038612A3 Canine and feline tumour-associated antigen 5t4
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2001075454A3 Diagnosis and treatment of alzheimer's disease
05/08/2003US20030088085 MPROT12 polynucleotides and methods thereof
05/08/2003US20030088075 Anti-human VEGF receptor Flt-1 monoclonal antibody
05/08/2003US20030088074 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains
05/08/2003US20030087870 Method of treating fibrosis
05/08/2003US20030087816 Anticancer, antitumor agents; genetic engineering
05/08/2003US20030087807 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity
05/08/2003US20030087801 Methods for treatment using novel ligands of the neuropeptide receptor hfgan72
1 ... 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 ... 1494